USPTO serial 79202497
ALBUMEDIX
Reviewed by CopyMark Law Group
Reg. 5388817Status 739Renewal
- Filing date
- Status date
- Registration date
- Jan 30, 2018
- Examiner
- SPARACINO, MARK V
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ALBUMEDIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,950
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Nottingham, GB
DK-2800 Kongens Lyngby, DK
DK-2800 Kongens Lyngby, DK
DK-2800 Kongens Lyngby, DK
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Karen Lim
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St., 17th FLNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for the manufacture of pharmaceutical products; chemical additives used in the manufacture of pharmaceutical preparations; albumin used in industry for the preparation of pharmaceutical compositions, reagents, and diagnostic reagents | ACTIVE | — |
| 005 | Pharmaceutical compositions and substances for the treatment of viral, metabolic, endocrine, urinary, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; diagnostic reagents for medical use and pharmaceutical medicinal use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for pharmaceutical and medical purposes; recombinant human albumin for pharmaceutical and medical purposes; diagnostic agents for medical imaging * [ ; pharmaceutical products and preparations for supporting drugs by reducing the time it takes for the body to break down the active pharmaceutical ingredient * ] | ACTIVE | — |
| 042 | Research and development services relating to pharmaceutical products; consultation in the field of development of medicines and pharmaceuticals as well as analysis and development services in the nature of pharmaceutical research and development services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Albumedix Ltd
- Other trademarks owned by Albumedix A/S
- Other trademarks owned by Albumedix A/S
- Other trademarks owned by Albumedix A/S
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ALBUMEDIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 16, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 16, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 16, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 16, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 16, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 19, 2024 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Nov 19, 2024 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Sep 23, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jan 12, 2024 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Apr 2, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 30, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 29, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 4, 2021 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Oct 11, 2021 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 23, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 11, 2021 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Feb 11, 2021 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Feb 11, 2021 | PLGL | ASSIGNED TO PARALEGAL | — |
| Nov 23, 2020 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Nov 23, 2020 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Nov 23, 2020 | PLGL | ASSIGNED TO PARALEGAL | — |
| Jul 3, 2020 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jul 3, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jan 31, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 11, 2018 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 6, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 8, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 8, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 30, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 30, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 23, 2017 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 14, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 14, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 25, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 6, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 4, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 4, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 4, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 4, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 4, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 13, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 13, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 13, 2017 | ALIE | ASSIGNED TO LIE | — |
| Sep 7, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 6, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 6, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 25, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 8, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 8, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 7, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 7, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 6, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 3, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 3, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 2, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |